VALTAMOX-CV
Cracks Resistance - Enhances Performance
-
Co-AmoxiClav demonstrated a higher efficacy rate than Cefixime and Ciprofloxacin.
-
Clinical success rates Cefpodoxime-proxetil group 92.3%.
-
Amoxicillin-clavulanic acid group 93.6%
-
More effective than Cefaclor, Cefuroxime, Cephalexin.
-
Higher efficacy rates than azithromycin in AECB.
-
More effective than Azithromycin in bacterial AOM
-
Better patient compliance
-
Safe & effective for Children
-
Offers cure rate of 95 % In UTI